• Something wrong with this record ?

The Degradation of Hyaluronan in the Skin

P. Žádníková, R. Šínová, V. Pavlík, M. Šimek, B. Šafránková, M. Hermannová, K. Nešporová, V. Velebný

. 2022 ; 12 (2) : . [pub] 20220203

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22019391

Hyaluronan (HA) comprises a fundamental component of the extracellular matrix and participates in a variety of biological processes. Half of the total amount of HA in the human body is present in the skin. HA exhibits a dynamic turnover; its half-life in the skin is less than one day. Nevertheless, the specific participants in the catabolism of HA in the skin have not yet been described in detail, despite the essential role of HA in cutaneous biology. A deeper knowledge of the processes involved will act to support the development of HA-based topical and implantable materials and enhance the understanding of the various related pathological cutaneous conditions. This study aimed to characterize the distribution and activity of hyaluronidases and the other proteins involved in the degradation of HA in healthy human full-thickness skin, the epidermis and the dermis. Hyaluronidase activity was detected for the first time in healthy human skin. The degradation of HA occurred in lysates at an acidic pH. HA gel zymography revealed a single band corresponding to approximately 50 kDa. This study provided the first comprehensive view of the distribution of canonic HA-degrading proteins (HYAL1 and HYAL2) in human skin employing IHF and IHC. Furthermore, contrary to previous assumptions TMEM2, a novel hyaluronidase, as well as CEMIP, a protein involved in HA degradation, were localized in the human epidermis, as well as in the dermis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019391
003      
CZ-PrNML
005      
20220804135621.0
007      
ta
008      
220720s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom12020251 $2 doi
035    __
$a (PubMed)35204753
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Žádníková, Petra $u R&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic $u Faculty of Medicine in Hradec Králové, Charles University, 500 03 Hradec Králové, Czech Republic
245    14
$a The Degradation of Hyaluronan in the Skin / $c P. Žádníková, R. Šínová, V. Pavlík, M. Šimek, B. Šafránková, M. Hermannová, K. Nešporová, V. Velebný
520    9_
$a Hyaluronan (HA) comprises a fundamental component of the extracellular matrix and participates in a variety of biological processes. Half of the total amount of HA in the human body is present in the skin. HA exhibits a dynamic turnover; its half-life in the skin is less than one day. Nevertheless, the specific participants in the catabolism of HA in the skin have not yet been described in detail, despite the essential role of HA in cutaneous biology. A deeper knowledge of the processes involved will act to support the development of HA-based topical and implantable materials and enhance the understanding of the various related pathological cutaneous conditions. This study aimed to characterize the distribution and activity of hyaluronidases and the other proteins involved in the degradation of HA in healthy human full-thickness skin, the epidermis and the dermis. Hyaluronidase activity was detected for the first time in healthy human skin. The degradation of HA occurred in lysates at an acidic pH. HA gel zymography revealed a single band corresponding to approximately 50 kDa. This study provided the first comprehensive view of the distribution of canonic HA-degrading proteins (HYAL1 and HYAL2) in human skin employing IHF and IHC. Furthermore, contrary to previous assumptions TMEM2, a novel hyaluronidase, as well as CEMIP, a protein involved in HA degradation, were localized in the human epidermis, as well as in the dermis.
650    _2
$a extracelulární matrix $x metabolismus $7 D005109
650    _2
$a lidé $7 D006801
650    12
$a kyselina hyaluronová $x chemie $7 D006820
650    12
$a hyaluronoglukosaminidasa $x metabolismus $7 D006821
650    _2
$a proteiny $x metabolismus $7 D011506
650    _2
$a kůže $x metabolismus $7 D012867
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šínová, Romana $u R&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic $u Institute of Experimental Biology, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic $1 https://orcid.org/0000000272829016
700    1_
$a Pavlík, Vojtěch $u R&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic $u Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic $1 https://orcid.org/0000000265759726
700    1_
$a Šimek, Matěj $u R&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic $1 https://orcid.org/000000029570315X
700    1_
$a Šafránková, Barbora $u R&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic
700    1_
$a Hermannová, Martina $u R&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic
700    1_
$a Nešporová, Kristina $u R&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic $1 https://orcid.org/0000000178647689
700    1_
$a Velebný, Vladimír $u R&D Department, Contipro a.s., 561 02 Dolní Dobrouč, Czech Republic
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 12, č. 2 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35204753 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135615 $b ABA008
999    __
$a ok $b bmc $g 1822826 $s 1170634
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 12 $c 2 $e 20220203 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
LZP    __
$a Pubmed-20220720
Back

Find record

Citation metrics

Archiving options